Jeisys Medical targets Latin America with Density and LinearZ at IMCAS Americas 2025
- Author
- Date
- 2025-04-13
- Views
- 163
Jeisys Medical successfully concluded its participation in ‘IMCAS Americas 2025’ held from April 11 (Fri) to 13 (Sun)
Introduced ‘DENSITY’ and ‘LinearZ’ to strengthen brand awareness in the Latin American market and attract attention
Expected to increase product demand through active networking with key KOLs and speakers in the region
Introduced ‘DENSITY’ and ‘LinearZ’ to strengthen brand awareness in the Latin American market and attract attention
Expected to increase product demand through active networking with key KOLs and speakers in the region
▲Jeisys Medical Co., Ltd. participated in ‘IMCAS Americas 2025’, held from April 11 to 13 at the World Trade Center São Paulo in Brazil, drawing high attention from buyers and experts in the region by introducing its flagship devices, Density and LinearZ.
Global medical aesthetics company Jeisys Medical Co., Ltd. accelerated its entry into the Latin American market by participating in the global aesthetic conference ‘IMCAS Americas 2025’, held from April 11 to 13 at the World Trade Center São Paulo, Brazil.
IMCAS Americas is the largest aesthetic and clinical conference in Latin America, where plastic surgeons, dermatologists, and aesthetic professionals gather to share the latest technologies and research.
Jeisys presented its radiofrequency-based medical aesthetic device ‘DENSITY’ and ultrasound-based device ‘LinearZ’ to officially introduce the products to the region. By highlighting its differentiated technology, Jeisys actively engaged with key opinion leaders (KOLs) and potential customers, establishing meaningful connections to expand its sales and distribution channels in the Latin American market.
In particular, booth visitors showed strong interest in Jeisys’s representative product, Density. Density delivers 6.78 MHz radiofrequency energy to the skin and applies both monopolar and bipolar RF modes in sequence.
A Jeisys Medical representative stated, “Our participation in IMCAS Americas 2025 provided a valuable opportunity to build stronger networks with top experts and enhance our brand awareness in the Latin American market,” adding, “We plan to launch active promotional campaigns in Brazil and other Latin American countries to expand product sales and distribution, and will continue to reinforce our presence in the global market through customized strategies for each region.”
Meanwhile, Jeisys Medical has been accelerating its global expansion since the beginning of the year. Starting with ‘IMCAS World Congress 2025’ held in Paris from January 30 to February 1, the company has been actively participating in major global congresses, and its involvement in ‘IMCAS Americas 2025’ reflects this ongoing strategy.
